Furosemide Stress Test Predicting Early Graft Function in Kidney Transplantation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorKing Chulalongkorn Memorial Hospital

About this trial

Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.

Eligibility criteria

Qualifiers

Deceased donor kidney transplantation at KCMH

informed consent is accepted

Disqualifiers

Known allergy to furosemide

Surgical complication of allograft

Urgently needed for dialysis (refractory hypervolemia, uremic symptoms, and hyperkalemia)

Trial design

Treatments tested in this trial

  • Furosemide Injection

Treatment groups

180 Participants
are divided into 1 treatment group